The Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all human infectious agents except HIV. DMID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, preclinical development, and clinical evaluation.
Research Focus
DMID conducts and supports research on nearly 300 infectious agents and investigates the biological properties of these pathogens and the immune system’s responses to them. Findings from this research are vital to NIAID efforts to create vaccines, drugs, and diagnostic tools to better diagnose, prevent, and treat infectious diseases.
Read more about the specific diseases and pathogens.
Product Development Support
DMID supports product development research in a variety of ways, including NIAID funding opportunities and solicitations, and services for each stage of the product development pathway.
Read more about more about support for infectious disease product developers.
News Releases
- NIH-Sponsored Trial of Lassa Vaccine Opens
March 17, 2025 - NIH-Funded Clinical Trial Will Evaluate New Dengue Therapeutic
February 11, 2025
NIAID Now Blog
- NIAID Research Key to H5N1 Influenza Preparedness Efforts
December 20, 2024 - Fungal Disease Awareness Week—Fighting Fungi at NIAID
September 20, 2024
Organization
Also see a list of DMID Contacts.
Funding Opportunities
NIAID and NIH offer a number of funding opportunities, including grants and contracts to conduct basic research, preclinical development, or clinical evaluation.
Read the Concepts–Potential Opportunities for potential funding opportunities from DMID.
Resources for Researchers
DMID supports a comprehensive set of resources for researchers. Their purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent infectious diseases.